Sanofi ranks third on the Access to Medicine Foundation’s 2012 ATM Index
Sanofi (EURONEXT: SAN and NYSE: SNY) ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM
Top 15 Drug Patent Losses for 2013
[column width=”360px” padding=”20px”]We are in the midst of third quarter earnings reports, and they show with stark detail what the
AstraZeneca, Lilly feeling real pain in race for arthritis drugs
[column width=”360px” padding=”20px”]The supercharged race to get new treatments into the lucrative market for treating rheumatoid arthritis (RA) appeared to
Cardiovascular Case Studies : Case study level 1 – Angina
[column] Learning outcomes Level 1 case study: You will be able to: describe the risk factors describe the disease describe
Respiratory System Case Studies: Case study level 1 – Asthma-Community
Learning outcomes Level 1 case study: You will be able to: describe the risk factors describe the disease describe the
Cardiovascular Case Studies : Case study level 2 – Hypertension
[column]Learning outcomes Level 2 case study: You will be able to: